Literature DB >> 18608870

Development of EBV-associated diffuse large B-cell lymphoma in Waldenstrom macroglobulinemia and mantle cell lymphoma.

Abraham M Varghese, Hazem Sayala, Paul A S Evans, Sheila J M O'Connor, Russell Patmore, Peter Hillmen, Roger G Owen.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18608870     DOI： 10.1080/10428190802123481

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  Rare transformation to double hit lymphoma in Waldenstrom's macroglobulinemia.

Authors:  Onyemaechi N Okolo; Ariel C Johnson; Seongseok Yun; Stacy J Arnold; Faiz Anwer
Journal:  Immunotherapy       Date:  2017-08-03       Impact factor: 4.196

2.  Welcome to the 9th Volume of Immunotherapy.

Authors:  Sonia Mannan
Journal:  Immunotherapy       Date:  2017-01       Impact factor: 4.196

3.  VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type.

Authors:  Ilaria Nichele; Alberto Zamò; Anna Bertolaso; Francesco Bifari; Martina Tinelli; Marta Franchini; Roberta Stradoni; Fiorenza Aprili; Giovanni Pizzolo; Mauro Krampera
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

4.  [Clonal-related transformation from Waldenström macroglobulinemia to diffuse large B cell lymphoma during the treatment of ibrutinib: a case report and literature review].

Authors:  Y Xia; H Y Zhu; L Wang; R Z Chen; W Chen; C Y Ding; W Xu; J Y Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.